Paper1283370
Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.
Beisland HO and 9 others. Eur Urol, 1992. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia. Papers, record 1283370. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1283370
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 5-alpha Reductase Inhibitors | Major topic |
| Androstenes | Major topic |
| Azasteroids | Major topic |
| Prostatic Hyperplasia | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Dihydrotestosterone | |
| Double-Blind Method | |
| Finasteride | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Osteocalcin | |
| Prostate-Specific Antigen | |
| Scandinavian and Nordic Countries | |
| Testosterone | |
| Urination |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20927745 | Finasteride for benign prostatic hyperplasia. | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20927745 | PubMed |
| 19936164 | Therapeutic options in the treatment of benign prostatic hyperplasia. | Patient Prefer Adherence | 2009 | https://conductscience.org/library/papers/19936164 | PubMed |
| 16323969 | Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options. | Drugs Aging | 2005 | https://conductscience.org/library/papers/16323969 | PubMed |
| 15260927 | The role of 5-alpha-reductase inhibition as monotherapy in view of the MTOPS data. | Curr Urol Rep | 2004 | https://conductscience.org/library/papers/15260927 | PubMed |
| 12962139 | Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats. | Mol Cell Biochem | 2003 | https://conductscience.org/library/papers/12962139 | PubMed |
| 12477383 | Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials. | BMC Urol | 2002 | https://conductscience.org/library/papers/12477383 | PubMed |
| 10235693 | Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia. | Drugs | 1999 | https://conductscience.org/library/papers/10235693 | PubMed |
| 9530536 | A risk-benefit assessment of treatment with finasteride in benign prostatic hyperplasia. | Drug Saf | 1998 | https://conductscience.org/library/papers/9530536 | PubMed |
| 9144895 | Conservative non-instrumental treatment of benign prostatic hyperplasia. | Urol Res | 1997 | https://conductscience.org/library/papers/9144895 | PubMed |
| 9061268 | Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective. | Drugs Aging | 1997 | https://conductscience.org/library/papers/9061268 | PubMed |
| 8911291 | Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study. | CMAJ | 1996 | https://conductscience.org/library/papers/8911291 | PubMed |
| 8846625 | Clinical pharmacokinetics and pharmacodynamics of finasteride. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8846625 | PubMed |
| 7691505 | Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia. | Drugs | 1993 | https://conductscience.org/library/papers/7691505 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1283370
GET https://conductscience.org/api/papers/v1/1283370/authors